Summary
| Direction in Hypertension | ↑ Elevated — higher than in the comparison group |
|---|---|
| Category | Cardiac |
| Compared against | hypertensive (asymptomatic, at-risk) vs normal |
| Test type | Blood test (serum / plasma / whole blood) |
| LOINC code | 33762-6 |
| Source | Bayes-Genis et al. 2023 — doi:10.1002/ejhf.3036 |
| Condition atlas | Hypertension Biomarker Atlas |
Other conditions where NT-proBNP is reported
- NT-proBNP in Atrial Fibrillation — ↑ elevated vs cardiac stress/AF vs healthy
- NT-proBNP in Long COVID — ↑ elevated vs HC
See the cross-condition hub: NT-proBNP across conditions.
Related Cardiac markers in Hypertension
Full list: Hypertension Biomarker Atlas.
Frequently asked questions
Is NT-proBNP high or low in Hypertension?
Elevated. Studies summarised in the OSMF atlas report higher NT-proBNP in Hypertension than in the reference group of the cited comparison (hypertensive (asymptomatic, at-risk) vs normal). Source: Bayes-Genis et al. 2023.
Which test measures NT-proBNP?
It is measured as a blood test (serum / plasma / whole blood). The standard laboratory code is LOINC 33762-6. Many of the cited studies used research-grade assays, so clinical availability may vary.
Is one abnormal NT-proBNP result diagnostic of Hypertension?
No. No single biomarker is diagnostic of Hypertension. NT-proBNP findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.
Is NT-proBNP specific to Hypertension?
No. The same marker is also reported in Atrial Fibrillation, Long COVID in this atlas, so it reflects shared biology (for example inflammation or vascular stress) rather than a condition-specific signature.
Cite this page
Subscribe on Substack
Last reviewed: 2026-07-03 · Page generated from hypertension.json · Browse: Hypertension atlas · Biomarker Index · All marker pages
Disclaimer: This page is an educational synthesis of published, peer-reviewed research and is not medical advice. Biomarker findings vary across studies with case definitions, comparison groups, timing and assay methods. Direction of change reflects the predominant finding in the cited source and does not establish a diagnostic threshold. Discuss any test result with a qualified clinician.